Gold nanoparticles to improve HIV drug delivery.
暂无分享,去创建一个
D. Margolis | Daniel. C. Whitehead | Jamee Bresee | Carly J. Carter | C. Melander | D. Feldheim | C. Garrido | Carrie A. Simpson | Noelle P. Dahl | E. A. Lindsey | Tyler L. Harris | Candice A Smith | Candice A. Smith
[1] K. Pettigrew,et al. Regional cerebrovascular permeability to [14C]sucrose after osmotic opening of the blood-brain barrier , 1978, Brain Research.
[2] R. Lanford,et al. Signal-mediated nuclear transport in simian virus 40-transformed cells is regulated by large tumor antigen. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[3] H. von Briesen,et al. Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro , 1996, Antimicrobial agents and chemotherapy.
[4] R. Chaisson,et al. Highly Active Antiretroviral Therapy in a Large Urban Clinic: Risk Factors for Virologic Failure and Adverse Drug Reactions , 1999, Annals of Internal Medicine.
[5] Yanli Liu,et al. Cellular trajectories of peptide-modified gold particle complexes: comparison of nuclear localization signals and peptide transduction domains. , 2004, Bioconjugate chemistry.
[6] Jesus M de la Fuente,et al. Tat peptide as an efficient molecule to translocate gold nanoparticles into the cell nucleus. , 2005, Bioconjugate chemistry.
[7] Leon Hirsch,et al. Gold nanoshell bioconjugates for molecular imaging in living cells. , 2005, Optics letters.
[8] Chad A. Mirkin,et al. Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation , 2006, Science.
[9] Mansoor M. Amiji,et al. Intracellular Delivery of Saquinavir in Biodegradable Polymeric Nanoparticles for HIV/AIDS , 2006, Pharmaceutical Research.
[10] Chad A Mirkin,et al. Gold nanoparticle probes for the detection of nucleic acid targets. , 2006, Clinica chimica acta; international journal of clinical chemistry.
[11] Arezou A Ghazani,et al. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.
[12] Drug targeting to the brain. , 2007, Annual review of pharmacology and toxicology.
[13] E. Zubarev,et al. Paclitaxel-functionalized gold nanoparticles. , 2007, Journal of the American Chemical Society.
[14] K. Overton,et al. Cellular uptake of gold nanoparticles passivated with BSA-SV40 large T antigen conjugates. , 2007, Analytical chemistry.
[15] L. Zhang,et al. Nanoparticles in Medicine: Therapeutic Applications and Developments , 2008, Clinical pharmacology and therapeutics.
[16] Keishiro Tomoda,et al. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. , 2008, Colloids and surfaces. B, Biointerfaces.
[17] K. Landfester,et al. The First Step into the Brain: Uptake of NIO‐PBCA Nanoparticles by Endothelial Cells in vitro and in vivo, and Direct Evidence for their Blood–Brain Barrier Permeation , 2008, ChemMedChem.
[18] Christian Melander,et al. Inhibition of HIV fusion with multivalent gold nanoparticles. , 2008, Journal of the American Chemical Society.
[19] Petra Krystek,et al. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. , 2008, Biomaterials.
[20] X. Wu,et al. Solid Lipid Nanoparticles Enhance the Delivery of the HIV Protease Inhibitor, Atazanavir, by a Human Brain Endothelial Cell Line , 2008, Pharmaceutical Research.
[21] C. Katlama,et al. High rate of virologic suppression with raltegravir plus etravirine and darunavir/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results of the ANRS 139 TRIO trial. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] A. Gerdon,et al. Unexpected toxicity of monolayer protected gold clusters eliminated by PEG-thiol place exchange reactions. , 2010, Chemical research in toxicology.
[23] S. Penadés,et al. Gold nanoparticles capped with sulfate-ended ligands as anti-HIV agents. , 2010, Bioorganic & medicinal chemistry letters.
[24] H. Gendelman,et al. Nanoformulated Antiretroviral Drug Combinations Extend Drug Release and Antiretroviral Responses in HIV-1-Infected Macrophages: Implications for NeuroAIDS Therapeutics , 2010, Journal of Neuroimmune Pharmacology.
[25] Lawrence Tamarkin,et al. Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine , 2010, Clinical Cancer Research.
[26] Keith E Maier,et al. Identification of antibiotics using small molecule variable ligand display on gold nanoparticles. , 2010, Chemical communications.
[27] D. Cliffel,et al. Short-chain PEG mixed monolayer protected gold clusters increase clearance and red blood cell counts. , 2011, ACS nano.
[28] Sozanne R. Solmaz,et al. Molecular Architecture of the Transport Channel of the Nuclear Pore Complex , 2011, Cell.
[29] Kenneth A. Dawson,et al. Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population. , 2011, Nature nanotechnology.
[30] Marianne Frieri,et al. Immune Response to Nanomaterials: Implications for Medicine and Literature Review , 2013, Current Allergy and Asthma Reports.
[31] K. Hynynen,et al. Enhanced delivery of gold nanoparticles with therapeutic potential into the brain using MRI-guided focused ultrasound. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[32] Jinwoo Cheon,et al. A facile approach for the delivery of inorganic nanoparticles into the brain by passing through the blood-brain barrier (BBB). , 2012, Chemical communications.
[33] W. Law,et al. Anti-HIV-1 nanotherapeutics: promises and challenges for the future , 2012, International journal of nanomedicine.
[34] B. Ances,et al. HIV-associated neurocognitive disorder. , 2013, The Lancet. Infectious diseases.
[35] D. Cliffel,et al. In vivo toxicity, biodistribution, and clearance of glutathione-coated gold nanoparticles. , 2013, Nanomedicine : nanotechnology, biology, and medicine.
[36] K. Landfester,et al. Complex encounters: nanoparticles in whole blood and their uptake into different types of white blood cells. , 2013, Nanomedicine.
[37] C. Destache,et al. Polymeric nanoparticles containing combination antiretroviral drugs for HIV type 1 treatment. , 2013, AIDS research and human retroviruses.
[38] Huan‐Tsung Chang,et al. Highly efficient inhibition of human immunodeficiency virus type 1 reverse transcriptase by aptamers functionalized gold nanoparticles. , 2013, Nanoscale.
[39] R. Shoemaker,et al. Nanoscale structure-activity relationships, mode of action, and biocompatibility of gold nanoparticle antibiotics. , 2014, Journal of the American Chemical Society.
[40] M. Churchill,et al. Is the central nervous system a reservoir of HIV-1? , 2014, Current opinion in HIV and AIDS.